A drug selected for the latest round of Medicare drug price negotiations stands to get dropped because a lower-cost biosimilar version of it is slated to hit the market this year.
Students seeking admission to selective schools face the dilemma of trying to get noticed for identical distinctions ...
I've noticed a lot of confusion in the industry between what is described as personalisation and what is actually sophisticated segmentation.
Vecima Networks Inc. (TSX: VCM) today reported financial results for the three and six months ended December 31, 2025.
OSHA requires PPE to properly fit each worker. Learn how poor PPE fit creates compliance risk, common violations, and how ...
Today’s environment demands clarity on ownership, outcomes and risk. To help leaders stand their ground in the current ...
The 2028 negotiation cycle marks another major inflection point in the implementation of the Medicare Drug Price Negotiation Program—its first year incorporating Part B drugs and its first opportunity ...
Today, AI is increasingly embedded in systems of record—identity platforms, security operations, customer data pipelines, financial workflows. Once that happens, the risk profile changes entirely.
Doctorow: What I would do is contrast what happens when things aren’t great now with how I felt about what happened when things weren’t great before. So I think when I was a larva on the early ...
Portfolio Rece ipts of $874 million in Q4 2025 and $3,254 million for FY 2025 Portfolio Receipts growth of 18% in Q4 2025 and 16% for FY 2025 ...
Customer expectations are shifting, and engagement with traditional loyalty programs continues to decline. Many organizations still struggle to align loyalty initiatives with measurable business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results